BioConsortia, Inc.
PrivateLast Round
VC Round
Aug 1, 2025
Total Funding Raised
$49M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BioConsortia, Inc. is an agricultural biotechnology company that develops microbial products to protect plants, enhance fertility, and increase crop yields.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioConsortia, Inc. Comparables
Compare BioConsortia, Inc. with similar companies based on industry and business-model similarity.
BioConsortia, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 1, 2025 | ||||
| VC Round | Apr 1, 2024 | ||||
| VC Round | Apr 19, 2023 | ||||
| Series D | Mar 27, 2018 | ||||
| Series C | Nov 8, 2016 | ||||
Series B | Apr 7, 2014 |
BioConsortia, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Square 1 Bank | Debt |
| Khosla Ventures | Series B, Series D, Series C, Seed |
| Otter Capital | Series B, Series C, VC Round, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 47% MoM, reaching 1.4K.
- Jul 27, 2026
Open roles increased to 70, 140% of headcount.
Recent news
Latest coverage and updates
- hiresSep 18, 2026
BioConsortia Inc hired Matthew Mouw as Vice President of Business Development on Sep 21st '26.
- hiresSep 18, 2026
BioConsortia Inc hired Mouw as Vice President of Business Development on Sep 18th '26.
- hiresSep 18, 2026
BioConsortia Inc hired Matt as Vice President of Business Development on Sep 18th '26.
- recognized_asJul 20, 2026
BioConsortia Inc will be recognized as one of 10 finalists at Euroseeds2026 Congress on Oct 26th '26.
- attends_eventJul 20, 2026
BioConsortia Inc attends event Euroseeds2026 Congress.
BioConsortia, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioConsortia, Inc.'s valuation, stock price, and market status.
Is BioConsortia, Inc. a public or private company?
BioConsortia, Inc. is a private company.
What is the current stock price of BioConsortia, Inc.?
BioConsortia, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is BioConsortia, Inc. worth (valuation)?
Valuation information for BioConsortia, Inc. is not publicly available.
Can I buy BioConsortia, Inc. stock?
BioConsortia, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioConsortia, Inc.'s last funding round?
BioConsortia, Inc.'s most recent funding round was VC Round on August 1, 2025.
Who are the main investors in BioConsortia, Inc.?
Key investors in BioConsortia, Inc. include Khosla Ventures, Otter Capital.
Will BioConsortia, Inc. IPO soon?
No public IPO plans have been announced for BioConsortia, Inc..
How can I track BioConsortia, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioConsortia, Inc.'s secondary market activity and sign up for updates.